Table 1.
The Molecular Targets and IC50 Values of the Antibodies Evaluated in this Study, and the HIV-1 Strains they Inhibit
Antibody | Molecular Target | HIV Isolates Inhibited | Target Cells Used for IC50 Determination for IIIB | IC50 for HIV-1IIIB (µg/ml)‡ | References |
---|---|---|---|---|---|
IgG1 b12 | gp120 | IIIB, MN and some primary isolates | H9† | 0.007 | [8] |
2G12 | gp120 | IIIB, RF, MN (weakly), SF2 (weakly) | AA-2 | 0.02 | [9] [10] |
IgG1 m14 | gp120 | IIIB (HxB2), JRCSF, 89.6, Yu2 | U87.CD4.CCR5.CXCR4 | 1.0 | [11] |
4E10 | gp41 | IIIB, MN, RF (weakly) & broad range of isolates | AA-2§ | 1.0§ | [7] |
2F5 | gp41 | IIIB, MN, SF2 & broad range of isolates | H9 U937 PBMC |
0.3 0.13 0.8 |
[6] |
IC50 values were derived from infectivity measurements utilizing free virus, and subsequent p24 production, unless indicated otherwise.
Cells were infected with cell-free virus and syncytium formation after 5 days was used as the readout.
IC50 values were derived from a plaque assay.